3,4,5,6,13,14,15,15a-Octahydro-9,13,14-trihydroxy-11-methoxy-6-methyl-2H-oxireno[h][2]benzoxacyclotetradecin-2,8(1aH)-dione
|
|
3,4,5,6,13,14,15,15a-Octahydro-9,13,14-trihydroxy-11-methoxy-6-methyl-2H-oxireno[h][2]benzoxacyclotetradecin-2,8(1aH)-dione Eigenschaften
Sicherheit
3,4,5,6,13,14,15,15a-Octahydro-9,13,14-trihydroxy-11-methoxy-6-methyl-2H-oxireno[h][2]benzoxacyclotetradecin-2,8(1aH)-dione Chemische Eigenschaften,Einsatz,Produktion Methoden
3,4,5,6,13,14,15,15a-Octahydro-9,13,14-trihydroxy-11-methoxy-6-methyl-2H-oxireno[h][2]benzoxacyclotetradecin-2,8(1aH)-dione Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
3,4,5,6,13,14,15,15a-Octahydro-9,13,14-trihydroxy-11-methoxy-6-methyl-2H-oxireno[h][2]benzoxacyclotetradecin-2,8(1aH)-dione Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 0)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate |
---|
- 3,4,5,6,13,14,15,15a-Octahydro-9,13,14-trihydroxy-11-methoxy-6-methyl-2H-oxireno[h][2]benzoxacyclotetradecin-2,8(1aH)-dione
- Dihydrohypothemicin